{
    "id": "5e323e93fbd6abf43b000059",
    "question": "Does head ct increase brain tumor risk?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the relationship between head CT scans and the risk of brain tumors. Document [0] mentions that radiation therapy for cancers such as Hodgkin lymphoma may increase the risk of secondary cancers, including myeloid leukemia, myelodysplastic syndrome, and solid tumors. However, this is not directly related to head CT scans. Document [9] discusses the risks of CT scans, including radiation exposure. It states that CT scans can increase the risk of radiation exposure, but it does not specifically mention a link between head CT scans and brain tumor risk. Document [25] provides information on the safety of CT scans, including the radiation exposure associated with brain CT studies. It states that the radiation exposure from a routine brain CT study is normally between 2 and 5 millisieverts (mSv). However, it does not establish a direct link between head CT scans and brain tumor risk. Document [30] discusses the treatment of brain metastases and the role of surgery and radiation therapy. It mentions that surgical extirpation may be undertaken for a single parenchymatous metastasis, but it does not mention a link between head CT scans and brain tumor risk. Document [31] compares stereotactic radiotherapy alone or combined with whole-brain radiation for metastases and does not mention a link between head CT scans and brain tumor risk. Based on the available information, there is no clear evidence to suggest that head CT scans increase the risk of brain tumors. However, it is essential to consider the radiation exposure associated with CT scans and the potential risks of radiation therapy for cancer treatment. Therefore, the answer to the question is: \", \"} \"answer_choice\": \"B\"",
    "snippets": [
        {
            "id": "Pathology_Robbins_1971",
            "title": "Pathology_Robbins",
            "content": "myeloid leukemia, myelodysplastic syndrome, and solid tumors, in individuals who received radiation therapy for cancers such as Hodgkin lymphoma. It is believed that the risk of secondary cancers following irradiation is greatest in children. This is based in part on a large-scale epidemiologic study showing that children who receive at least two CT scans have very small but measurable increased risks for leukemia and malignant brain"
        },
        {
            "id": "Neurology_Adams_5003",
            "title": "Neurology_Adams",
            "content": "from another perspective, in the United States, the yearly incidence of all tumors that involve the brain is 46 per 100,000, and of primary brain tumors, 15 per 100,000. In part, the current high incidence of neoplasms of the brain in comparison to past epochs is probably the result of the availability and high utilization of cranial imaging."
        },
        {
            "id": "Neurology_Adams_5169",
            "title": "Neurology_Adams",
            "content": "There remains a controversial issue of prophylactic radiation of the entire cranium in the case of certain tumors, particularly small cell lung cancer. Information from a trial by Slotman and colleagues and an older one by Aup\u00e9rin and coworkers in patients with chemotherapy-responsive small cell lung cancer suggests that prophylactic radiation prolonged survival by 1.5 months and markedly reduced the later emergence of metastasis to the brain. Critics have noted that, with recently improving survival rates, the later cognitive effects of brain radiation may become evident."
        },
        {
            "id": "Neurology_Adams_5163",
            "title": "Neurology_Adams",
            "content": "When any of the several clinical syndromes caused by metastatic tumor is fully developed, diagnosis is relatively easy. If only headache and vomiting are present, a common problem is to attribute them to migraine or tension headache. One should invoke such explanations only if the patient has the standard symptoms of one of these conditions. CT with contrast will detect practically all sizable (1 cm) metastases though MRI with gadolinium is much more sensitive especially for cerebellar and subcentimeter lesions, and will expose associated leptomeningeal disease. Multiple nodular deposits of tumor in the brain on imaging studies most clearly distinguish metastatic cancer from other tumors but this pattern may also occur with brain abscesses, brain lymphoma, and glioblastoma."
        },
        {
            "id": "Neurology_Adams_5334",
            "title": "Neurology_Adams",
            "content": "Other Tumors of the Base of the Skull"
        },
        {
            "id": "InternalMed_Harrison_21307",
            "title": "InternalMed_Harrison",
            "content": "About 25% of patients with cancer die with intracranial metastases. The cancers that most often metastasize to the brain are lung and breast cancers and melanoma. Brain metastases often occur in the presence of systemic disease, and they frequently cause major symptoms, disability, and early death. The initial presentation of brain metastases from a previously unknown primary cancer is common. Lung cancer is most commonly the primary malignancy. Chest/ abdomen CT scans and brain MRI as the initial diagnostic studies can identify a biopsy site in most patients."
        },
        {
            "id": "Neurology_Adams_5067",
            "title": "Neurology_Adams",
            "content": "Sooner or later, focal cerebral signs will be discovered in most patients with brain tumors. Most often the focal signs are at first slight and subtle, but some patients present with such signs. In the modern era of ubiquitous imaging for all manner of cerebral complaints, CT or MRI often will have disclosed the presence of a tumor before either focal cerebral signs or the signs of increased intracranial pressure have become evident. The cerebral tumors that are most likely to produce the syndromes of asthenia, headache, seizures, or focal signs are the ones discussed below."
        },
        {
            "id": "InternalMed_Harrison_7591",
            "title": "InternalMed_Harrison",
            "content": "No underlying cause has been identified for the majority of primary brain tumors. The only established risk factors are exposure to ionizing radiation (meningiomas, gliomas, and schwannomas) and immunosuppression (primary CNS lymphoma). Evidence for an association with exposure to electromagnetic fields including cellular telephones, head injury, foods containing N-nitroso compounds, or occupational risk factors are unproven. A small minority of patients have a family history of brain tumors. Some of these familial cases are associated with genetic syndromes (Table 118-2)."
        },
        {
            "id": "Neurology_Adams_5411",
            "title": "Neurology_Adams",
            "content": "Cairncross JG, MacDonald DR: Chemotherapy for oligodendroglioma: Progress report. Arch Neurol 48:225, 1991. Carvalho PA, Schwartz RB, Alexander E, et al: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77:565, 1992. Cavin LW, Dalrymple GV, McGuire EL, et al: CNS tumor induction by radiotherapy: A report of four new cases and estimate of dose required. Int J Radiat Oncol Biol Phys 18:399, 1990. Chang SD, Alder JR: Treatment of cranial base meningiomas with linear accelerator radiosurgery. Neurosurgery 41:1019, 1997. Clouston PD, DeAngelis LM, Posner JB: The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268, 1992. Cogan DG: Tumors of the optic nerve. In: Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. Vol 17. Amsterdam, North-Holland, 1974, pp 350\u2013374. Colao A, Lombardi G: Growth-hormone and prolactin excess. Lancet 352:1455, 1998."
        },
        {
            "id": "Neurology_Adams_143",
            "title": "Neurology_Adams",
            "content": "Risks of CT The primary risk of CT is radiation exposure, and overexposure can have clinical consequences ranging from relatively benign alopecia to leukomalacia and neoplasia. The interested reader should refer to FDA guidelines on the subject (http://www.fda.gov/Radiation-emittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MedicalX-Rays/ucm115317.htm). Given the need for repeated CT examinations in certain patients, tracking of total radiation exposure may be advisable and may find greater use in the future. CT is usually deferred during pregnancy unless the mother\u2019s health is at imminent risk (i.e., following trauma). The potential harm to a fetus from radiation depends on gestational age and total absorbed dose. It is noteworthy that the fetal radiation dose from maternal cranial CT is lower than from maternal pelvic CT."
        },
        {
            "id": "First_Aid_Step2_605",
            "title": "First_Aid_Step2",
            "content": "(A) CT scan without contrast reveals blood in the subarachnoid space at the base of the brain (arrows). (B) A normal CT scan without contrast shows no density in this region (arrows). (Reproduced, with permission, from Aminoff MJ. Clinical Neurology, 3rd ed. Stamford, CT: Appleton & Lange, 1996: 78.) \u25a0 Surgical clipping is the defnitive treatment for aneurysms. Endovascular coiling is an option for poor surgical candidates. Risk factors include hypertension, tumor, amyloid angiopathy (in the elderly), anticoagulation, and vascular malformations (AVMs, cavernous hemangiomas). Hx/PE: Presents with focal motor and sensory defcits that often worsen as the hematoma expands. Severe headache of sudden onset, nausea/ vomiting, seizures, lethargy, or obtundation may also be seen. Dx: Immediate noncontrast head CT (see Figure 2.10-5). Look for mass effect or edema that may predict herniation."
        },
        {
            "id": "Neurology_Adams_5339",
            "title": "Neurology_Adams",
            "content": "Modern imaging techniques now serve to clarify many of the diagnostic problems posed by these tumors. MRI is particularly helpful in delineating structures at the base of the brain and in the upper cervical region. CT is also capable of determining the absorptive values of the tumor itself and the sites of bone erosion. When the lesion is analyzed in this way, an etiologic diagnosis often becomes possible. For example, the absorptive value of lipomatous tissue is different from that of brain tissue, glioma, blood, and calcium. Bone scans (technetium and gallium) display active destructive lesions with remarkable fidelity, but in some cases, even when the tumor is seen with various studies, it may be difficult to obtain a satisfactory biopsy. Tumors of the Foramen Magnum"
        },
        {
            "id": "Neurology_Adams_7191",
            "title": "Neurology_Adams",
            "content": "Schneider AL, Wang, D, Ling G, et al: Prevalence of and risk factors for self-reported previous head injury in the United States. New Engl J Med 379:1176, 2018. Shatsky SA, Evans DE, Miller F, Martins AN: High speed angiography of experimental head injury. J Neurosurg 41:523, 1974. Shaw NA: The neurophysiology of concussion. Prog Neurobiol 67:281, 2002. Simon B, Letourneau P, Vitorino E, et al: Pediatric head trauma: Indications for computed tomographic scanning revisited. J Trauma 51:231, 2001. Skippen P, Seear M, Poskitt K, et al: Effect of hyperventilation on regional cerebral blood flow in head-injured children. Crit Care Med 25:1402, 1997. Smits M, Dippel DW, de Haan GG, et al: External validation of the Canadian CT head rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA 294:1519, 2005."
        },
        {
            "id": "Neurology_Adams_5083",
            "title": "Neurology_Adams",
            "content": "Cranial irradiation to a total dose of 6,000 cGy increases survival by 5 months on average (see in the following text). This is true even in the elderly who have had only a biopsy without resection according to a trial conducted by Keime-Guibert and colleagues. In many centers, a fraction of this is delivered as a \u201cboost\u201d through focused or stereotactic radiation, particularly if the tumor is small enough to encompass in these fields. Brachytherapy (implantation of iodine-125 or iridium-193 beads or needles) and high-dose focused radiation (stereotactic radiosurgery) have so far not significantly altered survival times but continue to be studied. They have gone through periods of popularity but are currently used only sparsely, partly because they cause local radiation necrosis."
        },
        {
            "id": "Pediatrics_Nelson_3787",
            "title": "Pediatrics_Nelson",
            "content": "Imaging the brain and spinal cord is accomplished using CT or magnetic resonance imaging (MRI). CT is quick and accessible for emergency purposes. MRI provides fine detail and, with different sequences, permits detection of posterior fossa lesions, subtle cerebral abnormalities, vascular anomalies, low-grade tumors, and ischemic changes. For a child with a head injury or sudden headache, cranial CT is the study of choice because it can rapidly reveal intracranial hemorrhage or other large lesions. For a child with new-onset complex partial seizures, MRI is the study of choice, because an area of focal cortical dysplasia or other subtle lesions might not be apparent on CT. MRI also provides excellent views of the spinal cord. Cranial ultrasonography is a noninvasive bedside procedure used to visualize the brain and ventricles of infants and young children with open fontanelles."
        },
        {
            "id": "InternalMed_Harrison_30898",
            "title": "InternalMed_Harrison",
            "content": "that justify CT scanning. It may be appropriate to be more liberal in obtaining CT scans in children because a small number, even without loss of consciousness, will have intracranial traumatic lesions but this exposes the child to radiation."
        },
        {
            "id": "First_Aid_Step2_669",
            "title": "First_Aid_Step2",
            "content": "Hemispheric tumors often produce visual field abnormalities and neuropsychiatric symptoms, including personality changes, lethargy, syncope, cognitive decline, aphasia, apraxia, and depression. Parasellar lesions usually present with visual loss and/or diplopia. Posterior fossa lesions tend to present with gait ataxia or cranial nerve deficits and/or \u2191 ICP from obstructive hydrocephalus. Metastases that tend to present with intracranial hemorrhage include renal cell carcinoma, thyroid cancer, choriocarcinoma, and melanoma. \u25a0Contrast CT and MRI with and without gadolinium to localize and determine the extent of the lesion. Gadolinium-enhanced MRI is generally better for visualizing soft tissue tumors and vascularity, but CT is better for TABLE 2.10-10. Common 1\u00b0 Neoplasms"
        },
        {
            "id": "Neurology_Adams_5106",
            "title": "Neurology_Adams",
            "content": "CT and MRI reveal small ventricles and one or more large confluent areas of signal change (Fig. 30-5). Imaging studies characteristically show the tumor crossing and thickening the corpus callosum. Contrast enhancement is scant, differentiating the tumor from cerebral lymphoma, which otherwise may have a similar appearance. As the tumor advances, enhancing nodules may appear, suggesting the emergence of foci of high-grade glioma."
        },
        {
            "id": "Neurology_Adams_5205",
            "title": "Neurology_Adams",
            "content": "The diagnostic problem is resolved by CT or MRI, which is obtained in patients with symptoms of increased intracranial pressure, with or without focal signs. In addition to the tumors listed in the heading above, others that may present in this way are central neurocytoma, craniopharyngioma, and a high spinal cord, cervicomedullary junction tumor. In addition, with some of the gliomas discussed in the preceding section, increased intracranial pressure may occasionally precede the first focal cerebral signs. Medulloblastoma, Neuroblastoma, and Retinoblastoma Medulloblastoma Medulloblastoma is an invasive and rapidly growing tumor, mainly of childhood, that arises in the posterior part of the cerebellar vermis and neuroepithelial roof of the fourth ventricle in children. It accounts for 20 percent of childhood brain tumors. Rarely, it presents elsewhere in the cerebellum or other parts of the brain in adults (Peterson and Walker)."
        },
        {
            "id": "Pediatrics_Nelson_3309",
            "title": "Pediatrics_Nelson",
            "content": "Genetic conditions Down syndrome is associated with an estimated 10to 20-fold increased risk. Neurofibromatosis 1, Bloom syndrome, and ataxia-telangiectasia, among others, are associated with an elevated risk. Acute myeloid leukemias Chemotherapeutic agents Alkylating agents and epipodophyllotoxins increase risk. Genetic factors Down syndrome and neurofibromatosis 1 are strongly associated. Familial monosomy 7 and several other genetic syndromes are also associated with increased risk. Patients treated with radiation therapy for other cancers. Brain cancers Therapeutic ionizing radiation to the head Genetic factors Neurofibromatosis 1 is strongly associated with optic gliomas and, to a lesser extent, with other central nervous system tumors. Tuberous sclerosis and several other genetic syndromes are associated with increased risk. Hodgkin disease Family history Monozygotic twins and siblings are at increased risk. Infections Epstein-Barr virus is associated with increased risk."
        },
        {
            "id": "Surgery_Schwartz_12275",
            "title": "Surgery_Schwartz",
            "content": "should prompt a metastatic work-up, including CT scan of the chest, abdomen, and pelvis, and a bone scan.Management largely depends upon the primary tumor, overall tumor burden, patient\u2019s medical condition, and location and number of metastases. The beliefs of the patient and family regarding aggressive care must be considered, with the primary goal of optimizing survival time while maintaining or improv-ing neurological function. Neurosurgical intervention can be indicated for a number of reasons. Biopsy can be obtained to provide a tissue diagnosis and further direct therapy. Hydro-cephalus from increased intracranial pressure due to intracranial tumor burden can be temporized via placement of a ventricu-loperitoneal shunt. Craniotomy can be used for debulking of intracranial tumor burden or resection. Data from random-ized controlled trials have supported the use of craniotomy for tumor resection plus whole-brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) for"
        },
        {
            "id": "InternalMed_Harrison_21136",
            "title": "InternalMed_Harrison",
            "content": "The availability of CT and MRI has focused attention on causes of coma that are detectable by imaging (e.g., hemorrhage, tumor, or hydrocephalus). Resorting primarily to this approach, although at times expedient, is imprudent because most cases of coma (and confusion) are metabolic or toxic in origin. Furthermore, the notion that a normal CT scan excludes an anatomic lesion as the cause of coma is erroneous. Bilateral hemisphere infarction, acute brainstem infarction, encephalitis, meningitis, mechanical shearing of axons as a result of closed head trauma, sagittal sinus thrombosis, and subdural hematoma isodense to adjacent brain are some of the disorders that may not be detected. Nevertheless, if the source of coma remains unknown, a scan should be obtained."
        },
        {
            "id": "Neurology_Adams_5402",
            "title": "Neurology_Adams",
            "content": "CT and MRI show a contrast-enhancing lesion, and by angiography there is an avascular mass. Small calcifications may appear many years after the radiation. MRI is somewhat more sensitive in distinguishing radiation necrosis from tumor and peritumor products, but PET is the most reliable way of differentiating the two, perhaps obviating the need for biopsy (Glantz et al, 1991). Single-photon emission tomography (SPECT) can be useful for this purpose as well (Carvalho et al). CT or MRI perfusion imaging can also be used to differentiate radiation necrosis from tumor progression; cerebral blood volume is reduced in the former and most often elevated in the latter."
        },
        {
            "id": "InternalMed_Harrison_21309",
            "title": "InternalMed_Harrison",
            "content": "CT scan and MRI are equally effective in the diagnosis of brain metastases. CT scan with contrast should be used as a screening procedure. The CT scan shows brain metastases as multiple enhancing lesions of various sizes with surrounding areas of low-density edema. If a single lesion or no metastases are visualized by contrast-enhanced CT, MRI of the brain should be performed. Gadolinium-enhanced MRI is more sensitive than CT at revealing meningeal involvement and small lesions, particularly in the brainstem or cerebellum. Intracranial hypertension (\u201cpseudotumor cerebri\u201d) secondary to tretinoin therapy has been reported."
        },
        {
            "id": "Pediatrics_Nelson_3957",
            "title": "Pediatrics_Nelson",
            "content": "The cause of increased ICP is determined by brain imaging with either head CT or brain MRI. CT is rapid, readilyavailable, and provides clear visualization of an acute hemorrhage or dilated ventricles. Mass lesions, hydrocephalus,and trauma are easily recognized. Diffuse brain swelling produced by hypoxic-ischemic injury, meningitis, encephalitis,metabolic abnormalities, or toxins may be better delineated by MRI. MRI is also superior to CT for visualizing the posterior fossa and cortical contusions. LP is the diagnostic testfor infection and for documentation of elevated ICP (essential for patients with idiopathic intracranial hypertension).However, LP is contraindicated in the setting of an intracranial mass lesion or clear hydrocephalus, because withdrawalof CSF can change pressures between the intracranial compartments and promote brainstem shifts and herniation.Idiopathic intracranial hypertension is diagnosed whendirect measurement of ICP with a manometer during LPreveals"
        },
        {
            "id": "InternalMed_Harrison_29423",
            "title": "InternalMed_Harrison",
            "content": "CT is safe, fast, and reliable. Radiation exposure depends on the dose used but is normally between 2 and 5 mSv (millisievert) for a routine brain CT study. Care must be taken to reduce exposure when imaging children. With the advent of MDCT, CTA, and CT perfusion, the benefit must be weighed against the increased radiation doses associated with these techniques. Advanced noise reduction software now permits acceptable diagnostic CT scans at 30\u201340% lower radiation doses. The most frequent complications are those associated with use of intravenous contrast agents. While two broad categories of contrast media, ionic and nonionic, are in use, ionic agents have been largely replaced by safer nonionic compounds."
        },
        {
            "id": "Neurology_Adams_10247",
            "title": "Neurology_Adams",
            "content": "and colleagues in 2009 but the techniques change so rapidly that it is difficult to determine and compare outcomes. The issue of radiosensitivity of any particular tumor has become a relative one as high doses of focal radiation are being delivered in one or a few fractions by special (stereotactic) techniques."
        },
        {
            "id": "InternalMed_Harrison_26488",
            "title": "InternalMed_Harrison",
            "content": "Treatment usually involves transcranial or transsphenoidal surgical resection followed by postoperative radiation of residual tumor. Surgery alone is curative in less than half of patients because of recurrences due to adherence to vital structures or because of small tumor deposits in the hypothalamus or brain parenchyma. The goal of surgery is to remove as much tumor as possible without risking complications associated with efforts to remove firmly adherent or inaccessible tissue. In the absence of radiotherapy, about 75% of craniopharyngiomas recur, and 10-year survival is less than 50%. In patients with incomplete resection, radiotherapy improves 10-year survival to 70\u201390% but is associated with increased risk of secondary malignancies. Most patients require lifelong pituitary hormone replacement."
        },
        {
            "id": "InternalMed_Harrison_16701",
            "title": "InternalMed_Harrison",
            "content": "Patients with TE have focal or multifocal abnormalities demonstrable by CT or MRI. Neuroradiologic evaluation should include double-dose contrast CT of the head. By this test, single and frequently multiple contrast-enhancing lesions (<2 cm) may be identified. MRI usually demonstrates multiple lesions located in both hemispheres, with the basal ganglia and corticomedullary junction most commonly involved; MRI provides a more sensitive evaluation of the efficacy of therapy than does CT (Fig. 253-2). These findings are not pathognomonic of Toxoplasma infection, because 40% of CNS lymphomas are multifocal and 50% are ring-enhancing. For both MRI and CT scans, the rate of false-negative results is ~10%. The finding of a single lesion on an MRI scan increases the likelihood of primary CNS lymphoma (in which solitary lesions are four times more likely than in TE) and strengthens the argument for the performance of a brain biopsy. A therapeutic trial of anti-Toxoplasma medications is"
        },
        {
            "id": "Neurology_Adams_5056",
            "title": "Neurology_Adams",
            "content": "In the further exposition of this subject, intracranial tumors are considered in relation to these common modes of clinical presentation: 1. Patients who present with focal cerebral signs and general impairment of cerebral function, headaches, or seizures 2. Patients who present with evidence of increased intracranial pressure 3. Patients who present with specific intracranial tumor syndromes Patients Presenting with Generalized and Focal Impairment of Cerebral Function, Headaches, or Seizures Altered mental function, headache, dizziness, and seizures are the usual manifestations in this group of patients. Until the advent of modern imaging procedures, these were the patients who presented the greatest difficulty in diagnosis and about whom decisions were often made with a great degree of uncertainty. Their initial symptoms are vague, and not until some time has elapsed will signs of focal brain disease appear; when they do, they are not always of accurate localizing value."
        },
        {
            "id": "Neurology_Adams_5170",
            "title": "Neurology_Adams",
            "content": "In patients with a single parenchymatous metastasis (shown to be solitary by gadolinium-enhanced MRI), surgical extirpation may be undertaken provided that growth of the primary tumor and its systemic metastases is under good control and the metastasis is accessible to the surgeon and not located in a strategic motor or language area of the brain. Usually, excision is followed by radiation therapy to the entire brain. Patchell and coworkers have shown that survival and the interval between treatment and recurrence are longer and that the quality of life is better in patients treated in this way than in comparable patients treated with whole-brain radiation alone. Single or dual metastases from renal cell cancer, melanoma, and adenocarcinoma of the gastrointestinal tract lend themselves best to surgical removal, as implemented in the matched cohort study by Bindal and colleagues."
        },
        {
            "id": "Neurology_Adams_5167",
            "title": "Neurology_Adams",
            "content": "One randomized trial comparing stereotactic radiotherapy alone, or combined with whole-brain radiation for 1 to 4 metastases, found no difference in survival but there was a reduction in the frequency of recurrence at other sites in the brain when whole-brain treatment was added (Aoyama et al). Several other studies have suggested that control of local symptoms related to a metastasis is better with focused radiotherapy. However, with the exception of a single lesion from small cell lung cancer, there does not seem to be an advantage to either approach. If focused treatment has been used, whole-brain radiation can still be instituted at the time of a recurrence. Whether there is evidence to justify the routine implementation of this approach is not clear, especially as overall measures of the quality of life are not generally improved. An arbitrary limit of stereotactic treatment of four metastases arose as the field evolved but it appears that the results are similar with even"
        }
    ],
    "scores": [
        0.037315982409440354,
        0.027493582691602493,
        0.024082977207977207,
        0.022681244872846597,
        0.021727568206441446,
        0.021253460270163706,
        0.02060185185185185,
        0.02034255379927633,
        0.019363873282339402,
        0.019334952363160844,
        0.019324122479462285,
        0.018938169106401573,
        0.0187720882404335,
        0.01834862385321101,
        0.01819535191464726,
        0.017494270435446907,
        0.017379679144385027,
        0.017125292740046837,
        0.016946778711484593,
        0.016337285902503294,
        0.016302705201372537,
        0.015966921119592876,
        0.015358455378201963,
        0.015238095238095238,
        0.01488095238095238,
        0.014867237217467633,
        0.0148633770393354,
        0.01484931506849315,
        0.014796731765643684,
        0.014509605662285137,
        0.014479166666666668,
        0.014434643143544507
    ]
}